RNA motif discovery by SHAPE and mutational profiling (SHAPE-MaP) by Siegfried, Nathan A et al.
RNA motif discovery by SHAPE and mutational profiling 
(SHAPE-MaP)
Nathan A. Siegfried1,3, Steven Busan1,3, Greggory M. Rice1,3, Julie A.E. Nelson2, and Kevin 
M. Weeks1,4
1Department of Chemistry, University of North Carolina, Chapel Hill, NC 27599-3290
2Department of Microbiology and Immunology, University of North Carolina, Chapel Hill, NC 
27599
Abstract
Many biological processes are RNA-mediated, but higher-order structures for most RNAs are 
unknown, making it difficult to understand how RNA structure governs function. Here we 
describe SHAPE mutational profiling (SHAPE-MaP) that makes possible de novo and large-scale 
identification of RNA functional motifs. Sites of 2’-hydroxyl acylation by SHAPE are encoded as 
non-complementary nucleotides during cDNA synthesis, as measured by massively parallel 
sequencing. SHAPE-MaP-guided modeling identified greater than 90% of accepted base pairs in 
complex RNAs of known structure and was used to define a second-generation model for the 
HIV-1 RNA genome. The HIV-1 model contains all known structured motifs and previously 
unknown elements, including experimentally validated pseudoknots. SHAPE-MaP yields accurate 
and high-resolution secondary structure models, enables analysis of low abundance RNAs, 
disentangles sequence polymorphisms in single experiments, and will ultimately democratize 
RNA structure analysis.
Introduction
Higher-order structures govern most aspects of RNA function, modulating interactions with 
small molecule ligands, individual proteins, large multi-component complexes, and other 
small and large RNAs1,2. There are numerous features of RNA structure that are difficult or 
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impossible to determine from sequence-based analysis alone. Inclusion of data from 
chemical probing experiments, in which an RNA reacts with diagnostic chemical reagents in 
a structure-selective way, dramatically improves the accuracy of RNA structure modeling3.
Substantial effort has therefore been directed toward developing high-throughput approaches 
to analyze RNA secondary structure. Recently reported approaches for RNA structure 
analysis that use massively parallel sequencing to read out the results of enzymatic, SHAPE, 
or DMS probing have provided comprehensive support for large-scale comparative trends in 
transcript structure but have not been shown to yield accurate secondary structure models or 
enable novel motif discovery4–11. In general, these "-seq" approaches are not suited to 
recovering RNA structure probing information because they require complex RNA ligation 
and library preparation steps that result in substantial nucleobase and local structure biases. 
In addition, there is no known pathway for using enzyme or DMS probing data, which report 
on only a subset of nucleotides, to model complex RNAs accurately. Moreover, 
understanding many critical features of RNA folding mechanisms12, RNA-protein 
interactions13,14, and in-cell effects on RNA folding and structure15,16 require that all four 
RNA nucleotides be interrogated simultaneously.
Results
The MaP Strategy
Selective 2"-hydroxyl acylation analyzed by primer extension (SHAPE)17–19 experiments 
use 2"-hydroxyl-selective reagents that react to form covalent 2"-O-adducts at 
conformationally flexible RNA nucleotides, both under simplified solution conditions13,20 
and in cells15,16,21. Recent innovations that include SHAPE data as restraints in RNA 
structure prediction algorithms consistently yield highly accurate secondary structure models 
for structurally complex RNAs19,22. Here we quantify SHAPE chemical 
modifications17,19,20,23 in RNA in a single direct step by massively parallel sequencing (Fig. 
1). The approach exploits conditions that cause reverse transcriptase to misread SHAPE-
modified nucleotides and incorporate a nucleotide non-complementary to the original 
sequence in the newly synthesized cDNA. The positions and relative frequencies of SHAPE 
adducts are thus immediately, directly, and permanently recorded as mutations in the cDNA 
primary sequence, thereby creating a SHAPE mutational profile (SHAPE-MaP). In a 
SHAPE-MaP experiment, the RNA is treated with a SHAPE reagent or treated with solvent 
only, and the RNA is modified under denaturing conditions to control for sequence-specific 
biases in detection of adduct-induced mutations (Fig. 2a). RNA from each experimental 
condition is subjected to reverse transcription, and the resulting cDNAs are then prepared 
for massively parallel sequencing. Reactive positions are identified by subtracting data from 
the treated sample from data obtained from the untreated sample and by normalizing to data 
from the denatured control (Figs. 1 and 2b and Supplementary Figs. 1–3).
Structure Modeling: Validation
We initially examined the structure of the E. coli thiamine pyrophosphate (TPP) riboswitch 
aptamer domain in the presence and absence of saturating concentrations of the TPP ligand 
(Fig. 2). SHAPE-MaP profiles recapitulated the known reactivity pattern for the folded, 
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ligand-bound RNA (Figs. 2b, 2c) and accurately reported nucleotide-resolution reactivity 
differences that occur upon ligand binding (Figs. 2d, 2e). These results, and an analysis of 
the 1542-nt E. coli 16S rRNA (Supplementary Figs. 4, 5), demonstrate the ability of 
SHAPE-MaP to capture fine structural details for distinct RNA conformations at nucleotide 
resolution, accurately and reproducibly, and independently of nucleotide type. Because the 
SHAPE profiles are reconstructed from mutation frequencies derived from all sequencing 
reads, uncertainties in SHAPE reactivities can be estimated from the Poisson distribution of 
mutation events (Methods, Supplementary Figs. 5, 6).
Use of SHAPE data as pseudo-free energy change terms to constrain secondary structure 
modeling has been extensively benchmarked using RNA test sets specifically chosen to be 
challenging to conventional secondary structure modeling19,22. To assess the accuracy of 
SHAPE-MaP, we probed a subset of these RNAs, ranging in size from 78 to 2,904 
nucleotides, with the well-validated 1M7 reagent17 We also evaluated the "differential" 
SHAPE experiment that uses two additional reagents – 1M6 and NMIA – to detect non-
canonical and tertiary interactions and yields RNA structural models with consistent high 
accuracy, even for especially challenging RNAs19,23. The overall accuracy of SHAPE-MaP 
directed RNA structure modeling using differential reactivities, measured in terms of 
sensitivity (sens) and positive predictive value (ppv), was similar to and often superior to 
that of conventional SHAPE reactivities based on adduct-mediated termination of primer 
extension detected by capillary electrophoresis. The accuracy for recovery of accepted, 
canonical base pairs exceeded 90% (Fig. 3a).
SHAPE reactivities obtained using the MaP strategy are measured as many individual events 
by massively parallel sequencing. Reliability depends on adequate measurement of mutation 
rates. Accurate modeling of the 16S rRNA structure was achieved using a per nucleotide 
read depth of 2,000–5,000. This corresponds to 6 to 15 modifications above background per 
ribosomal nucleotide on average (the hit level; Fig. 3b and Online Methods). Although 
several prior studies have been performed in which all of the RNAs in a given transcriptome 
were physically present during the probing phase of the experiment, only a few thousand 
nucleotides in each case were sampled at a depth that would allow full recovery of the 
underlying structural information (see Online Methods for detailed analysis). Importantly, 
accurate SHAPE-MaP directed modeling was achieved using the same parameters originally 
defined for capillary electrophoresis-based experiments and comparable high accuracies 
were obtained using both RNA-specific and randomly primed experiments (Supplementary 
Fig. 3). Data were highly reproducible between experimental replicates performed months 
apart by different individuals (Supplementary Fig. 5), emphasizing the robustness of 
SHAPE-MaP.
A Second-Generation Model for an HIV-1 RNA Genome
We obtained single-nucleotide resolution structural information for the entire authentic 
HIV-1NL4-3 genomic RNA (~9,200 nts) in experiments and data analysis performed over 
roughly 2 weeks. The 1M7 and differential SHAPE-MaP data were processed to yield 
SHAPE reactivity profiles and secondary structure models using efficient and fully 
automated algorithms (Fig. 4, Supplementary Figs. 1–3, 7). Since our report in 2009 of a 
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model for the HIV-1 RNA genome, we have made multiple, fundamental advances in 
SHAPE-directed RNA structure modeling. These innovations include improved energy 
models, the ability to model pseudoknots, and concise strategies for detecting tertiary and 
non-canonical interactions19,22. The MaP approach, implemented in this work, yields 
nucleotide-resolution reactivity data for large RNAs that are equal or are superior to the 
prior gold standard capillary electrophoresis data (Fig. 3a). Thus, the HIV-1 genome 
structure presented here represents a higher resolution, second-generation model for well-
defined elements in this RNA.
De Novo Identification of Well-Determined Structures
Almost any long RNA sequence will form some secondary structures24, but not all of these 
structures are biologically important or well-defined. Therefore, we used SHAPE-directed 
modeling, whose underlying energy function yields highly accurate models for RNAs with 
well-defined secondary structures (Fig. 3), to calculate a probability for each base pair 
across all possible structures in the Boltzmann ensemble of structures predicted for the 
HIV-1 RNA. These probabilities were used, in turn, to calculate Shannon entropies25,26 
(Fig. 4). Regions with higher Shannon entropies are likely to form alternative structures, and 
those with low Shannon entropies correspond to regions with well-defined RNA structures 
or persistent single-strandedness, as determined by SHAPE reactivity.
The plot of pairing probability across the entire HIV-1 genome reveals both well-determined 
and variable RNA structures in the HIV-1 genomic RNA (Fig. 4a). Previously characterized 
structured regions such as the 5'-UTR, Rev response element (RRE), frameshift element, 
and polypurine tract (PPT) are well determined in the model (represented by green arcs). In 
contrast, there are also large regions – for example, from nucleotides 3200 to 4500 and from 
nucleotides 6100 to 6800 – that have high SHAPE reactivities and high Shannon entropy 
and are therefore likely to sample many conformations (shown as blue, yellow, and gray 
arcs). This visualization approach highlights regions with unique, likely stable structures and 
those regions where multiple structures are likely to be in equilibrium.
Critically, analysis of Shannon entropies and SHAPE reactivities provides an approach for 
de novo discovery of regions with well-defined structure in long RNAs. Fifteen regions in 
the HIV-1 genomic RNA had both low SHAPE reactivity values (indicating a high degree of 
RNA structure) and low Shannon entropies (providing confidence in a single predominant 
secondary structure) (Figs. 4a, 4b, shaded in purple). We created nucleotide-resolution 
structure models for each of these regions (Fig. 4c). The models of known, functionally 
important regulatory structures – RRE, 5' TAR, primer binding site (PBS), packaging 
element PSI structures, ribosomal frameshift element, and 3' TAR – agreed closely with 
previously proposed models for these regions. In addition, the longest continuous helix, the 
hairpins flanking the polypurine tract, and other features remain consistent between the 
prior27 and this second-generation model (Supplementary Table 1). We next assembled a list 
of all regulatory elements likely to function via an RNA motif (Fig. 4b; Supplementary 
Table 2). We then compared the locations of these RNA structural elements with the highly 
structured and low entropy regions identified de novo by SHAPE-MaP. Functional RNA 
elements occur overwhelmingly in low SHAPE, low Shannon entropy regions (p-value = 
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0.002; Fig. 4 and Online Methods), indicating that most RNA-mediated functions operate in 
the context of an underlying RNA structure. Several low SHAPE, low Shannon entropy 
regions in the HIV-1 genome occur in regions not previously associated with known RNA 
functional elements: These regions are high-value targets for discovery of new RNA motifs.
Motif Discovery and Deconvolution of Structural Polymorphism
Pseudoknots appear to be rare in large RNAs and are difficult to identify; however, these 
motifs appear to be overrepresented in functionally important regions of many RNAs28,29. 
As a rigorous test of the current cumulative advances in SHAPE-directed structure modeling 
and of the high-throughput SHAPE-MaP data itself, we searched22 for novel pseudoknots in 
the HIV-1 RNA genome. In our model, there are four pseudoknots in regions of low SHAPE 
reactivity and low Shannon entropy (Fig. 4c). The pseudoknot adjacent to the 5' 
polyadenylation signal in the HIV-1 RNA (5'PK) was previously validated13,30. The three 
additional, novel pseudoknots are predicted to form in the reverse transcriptase coding 
region (RTPK), at the beginning of env (ENVPK), and in the U3 region adjacent to the 3' 
polyadenylation signal (U3PK). An additional pseudoknot predicted by the ShapeKnots 
algorithm that lies in a region of high SHAPE reactivity and Shannon entropy (CAPK, nt 
961–1014, Supplementary Fig. 8) was analyzed as a negative control.
We introduced silent mutations designed to disrupt each pseudoknot into the full-length 
HIV-1 genome (Supplementary Fig. 8). Special features of the U3PK region illustrate the 
power of the MaP approach. U3 sequences occur at both the 5' and 3' ends of the viral 
genome in proviral HIV-1 DNA but only at the 3' end in the viral RNA. During transfection 
of the provirus-encoding plasmid, these sequences can undergo recombination. When we 
introduced a single mutant copy of the U3 sequence (at the 3' end) into the pNL4-3 provirus, 
we observed partial recombination with the native sequence U3 at the 5' end of the proviral 
DNA. SHAPE-MaP experiments revealed that both native and mutant sequences were 
present at the 3' ends of individual genomic RNAs in the mutant U3PK sample. Critically, 
because nucleotides are analyzed in the context of unfragmented RNA regions in the MaP 
approach, we were able to independently monitor both alleles in the same experiment, 
computationally separate them, and construct native and mutant SHAPE profiles (Figs. 5a, 
5b, Supplementary Fig. 9, and Online Methods). Notable SHAPE reactivity differences 
between native and mutant U3 were observed, produced by viruses in direct competition 
with each other and consistent with precise disruption of the U3PK structure (Figs. 5b and 
Supplementary Fig. 9). Strikingly, mutations introduced in the 5' side of the U3PK 
pseudoknot helix induced changes in the predicted 3' pairing partner, located over 100 
nucleotides away (Fig. 5b). SHAPE-MaP is thus uniquely useful for structural analysis and 
motif discovery in systems that contain complex mixtures of RNAs and for detecting and 
deconvoluting structural consequences of single-nucleotide and other allelic polymorphisms.
All mutant constructs were analyzed using SHAPE-MaP and in cell-based assays for viral 
fitness. Mutations in U3PK reduced viral spread in Jurkat cells by ~10-fold relative to NL4-3 
and reduced viral fitness in direct competition with NL4-3, with a mean relative fitness 
difference of –0.32 relative to NL4-3 (Fig. 5c)31. This large effect on viral fitness by 
mutations in the U3PK is consistent with the general importance of 3'-UTRs in regulating 
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mRNA stability and translation32 and, more specifically, with a role for specific higher-
order spatial organization of the poly(A) signal and upstream sequence elements in assembly 
of the polyadenylation machinery33,34. SHAPE changes in the RTPK mutant were also 
located directly in or immediately adjacent to the pseudoknotted helix (Fig. 5d). Mutations 
in RTPK showed a smaller, but reproducible, decrease in viral spread and viral fitness, with a 
mean relative fitness of –0.14, compared to NL4-3 (Fig. 5e). We also observed changes in 
SHAPE reactivities at both the 5' and 3' sequences for the long-distance ENVPK mutant, 
including changes extending 5' from the pseudoknotted helix, suggestive of local refolding 
caused by disruption of this pseudoknot (Supplementary Fig. 10). Viral spread and viral 
fitness were not reduced for the ENVPK mutant, which may reflect the challenge of 
detecting some features of HIV-1 replication in cell culture. The mutations in CAPK 
(Supplementary Fig. 10), which we analyzed as a negative control, did not support existence 
of a pseudoknotted structure at this location by SHAPE-MaP analysis, in agreement with its 
high Shannon entropy profile.
Discussion
This work defines an alternative strategy for reading out nucleic acid structure probing 
experiments by massively parallel sequencing. With mutational profiling, or MaP, nucleic 
acid structural information is directly and concisely recorded in the sequence of the 
complementary cDNA and rendered insensitive to biases in library preparation and 
sequencing. MaP thus converts reverse transcription or DNA synthesis into a direct engine 
for nucleic acid structure discovery. MaP is fully independent of sequencing strategy and 
can therefore be used in any sequencing approach with a sufficiently low base call error rate 
to quantify chemical modifications in any low-abundance RNA detectable by reverse 
transcription. Detection of chemical adducts in RNA and DNA via direct read-through can 
be coupled with strategies for polymerase selection35,36 to record, as mutational profiles or 
MaPs, a wide variety of post-transcriptional and epigenetic modifications. SHAPE-MaP data 
contain error estimates and are readily integrated into fully automated, vetted, algorithms for 
structure modeling (Online Methods). SHAPE-MaP yielded accurate models for RNAs of 
known structure (Fig. 3a) and of individual functional motifs in large RNA (Fig. 4) and 
makes possible transcript-wide motif discovery (Figs. 4 and 5).
In large- and genome-scale RNA structural studies, true functional elements must be 
identified in the background of the complex ensemble of structures that form in any large 
RNA. The combination of SHAPE-MaP analysis with analysis of pairing probabilities, 
calculated across large RNA regions, identified almost all known large-scale functional 
elements within the HIV-1 genome, with the exception of the central polypurine tract (cPPT; 
Fig. 4), which appears to have a conserved structure37. Thus, the sensitivity of functional 
element detection by SHAPE-MaP is very high. Moreover, despite the fact that the HIV-1 
genome is one of most intensively studied RNAs in scientific history, quantitative and high-
resolution SHAPE-MaP analysis nonetheless allowed rapid, de novo discovery and direct 
validation of new functional motifs, specifically three pseudoknots – a motif that has 
traditionally been challenging to predict (Figs. 4 and 5). The positive predictive value of the 
approaches developed here is thus also correspondingly high. SHAPE-MaP is unique in its 
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SHAPE-MaP experiments use specialized conditions for reverse transcription that promote 
incorporation of nucleotides non-complementary to the RNA into the nascent cDNA at the 
locations of SHAPE adducts. Sites of RNA adducts thus correspond to internal mutations or 
deletions in the cDNA, relative to comparison with cDNAs transcribed from RNA not 
treated with SHAPE reagent. Reverse transcription can be carried out using gene-specific or 
random primers (Supplementary Fig. 3); both approaches are described below. Once cDNA 
synthesis is complete, RNA structural information is essentially permanently recorded in the 
sequence and thus independent of biases introduced during any multi-step library 
construction scheme. Library preparation is similar to that of an RNA-seq experiment, can 
be readily tailored to any sequencing platform, and allows multiplexing using sequence 
barcodes. Single-stranded breaks and background degradation do not intrinsically interfere 
with SHAPE-MaP experiments (in contrast to conventional SHAPE and other reverse 
transcriptase stop-dependent assays), as these are not detected during read-through 
sequencing. There is also no signal decay or drop-off in the MaP approach, which otherwise 
requires complex, partially heuristic, correction.
SHAPE-MaP development and efficiency
Reverse transcriptase enzymes are, in some cases, able to read through unusual 2'-O-
linkages and adducts, following enzyme pausing39,40. We hypothesize that read-through 
causes, or results from, structural distortion in the reverse transcriptase active site, that 
results in a higher rate of nucleotide misincorporation at the location of a pause-inducing 
SHAPE adduct. We screened multiple reverse transcriptase enzymes for use in SHAPE-MaP 
as a function of nucleotide concentration, reaction time, buffer conditions, and divalent 
metal ion identity. We searched for enzyme conditions that produced minimal adduct-
induced reverse transcription stops and maximal full-length cDNA products. Of the divalent 
metal ions tested (including magnesium, manganese, copper, cobalt, nickel, and lead), Mn2+ 
most effectively promoted enzyme read-through at the sites of bulky 2'-O-adducts, 
particularly using a Moloney murine leukemia virus reverse transcriptase (Superscript II, 
Invitrogen). This observation is consistent with the high activity of the Moloney reverse 
transcriptase in Mn2+ 41 and the ability of this ion to promote mutagenic behavior in DNA 
polymerases42.
We determined the precise classes of adduct-induced misincorporation events by comparing 
substitution and deletion rates at non-paired and paired nucleotide positions in the 16S 
rRNA. Misincorporation trends were similar between all three SHAPE reagents (1M717 and 
the "differential" reagents NMIA and 1M619). Generally, the presence of a SHAPE adduct 
causes nucleotides to be misread as A, T, or deletion events, although there is significant 
information content in other misincorporation events (Supplementary Fig. 11). Flexible 
nucleotides in a dinucleotide model substrate with a single reactive position (AddC)17 are 
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modified with an efficiency of ~2% by NMIA or 1M7 under conditions similar to those used 
here. Mutation rates above background at flexible positions in the 16S rRNA are ≥0.5%, 
with many of the most reactive positions above 2% (Supplementary Fig. 4). Given these 
boundary values, we estimate that the MaP strategy detects SHAPE adducts with an 
efficiency of ≥50%.
RNA folding and SHAPE probing of model RNAs
DNA templates (IDT) were synthesized for tRNAPhe, TPP riboswitch, E. coli 5S, hepatitis C 
virus IRES domain, T. thermophila group I intron, or O. iheyensis group II intron RNAs in 
the context of flanking 5' and 3' structure cassettes. Templates were amplified by PCR and 
transcribed into RNA using T7 RNA polymerase43. RNAs were purified by denaturing 
polyacrylamide gel electrophoresis, appropriate regions excised, and RNAs passively eluted 
from the gel overnight at 4 °C. 16S and 23S rRNAs were isolated from DH5α cells during 
mid-log phase using non-denaturing conditions38. For each sample, 5 pM of RNA was 
refolded in 100 mM HEPES, pH 8.0, 100 mM NaCl, and 10 mM MgCl2 in a final volume of 
10 µL. After folding, RNAs were modified in the presence of 10 mM SHAPE reagent and 
incubated at 37 °C for 3 min (1M6 and 1M7) or 22 min (NMIA). No-reagent controls, 
containing neat DMSO rather than SHAPE reagent, were performed in parallel. To account 
for sequence-specific biases in adduct detection, RNAs were modified using NMIA, 1M7, or 
1M6 under strongly denaturing conditions in 50 mM HEPES (pH 8.0), 4 mM EDTA, and 
50% formamide at 95 °C. Following modification, RNAs were isolated using either RNA 
affinity columns (RNeasy MinElute; Qiagen) or G-50 spin columns (GE Healthcare).
RNA folding and SHAPE probing of the HIV-1 genomic RNA
For whole-genome SHAPE-MaP of HIV-1 (strain NL4-3; group M, subtype B), virus was 
produced and purified as described27. Viral RNA was gently extracted and purified from 
protein then precipitated with ethanol from a solution containing 300 mM NaCl. 
Approximately 30% of genomic RNA is full length when prepared in this manner27; the 
fragmented nature of native HIV-1 genome samples resulted in decreased sample recovery 
during column purifications (RNeasy MinElute, Qiagen). Therefore, ~1 µg of HIV-1 RNA 
was used per sample, more RNA than the 250 ng required for SHAPE-MaP experiments of 
more intact RNAs.
Mutant viruses were produced by transfection of 293T cells using FuGene6 (Promega) or 
XtremeGene HP (Roche). Viral supernatants were concentrated using centrifugal 
concentrators (Vivaspin 20, Sartorius), followed by precipitation (Lenti-X Concentrator, 
Clontech) to concentrate virions. Pelleted virions were resuspended in viral lysis buffer [50 
mM HEPES (pH 8.0), 200 mM NaCl, 3 mM MgCl2]27, and lysed with 1% (w/v) SDS and 
100 µg/mL proteinase K (25 °C, 30 min). RNA was extracted with 
phenol:chloroform:isoamyl alcohol at least three times, followed by two extractions with 
chloroform and precipitation with ethanol.
Approximately 1 µg of HIV-1 genomic RNA was suspended in modification buffer [50 mM 
HEPES (pH 8.0), 200 mM potassium acetate (pH 8.0), 3 mM MgCl2] and incubated at 37 °C 
for 15 min (for SHAPE modified and untreated samples) or in denaturing buffer [50 mM 
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HEPES (pH 8.0), 4 mM EDTA, and 50% formamide] and incubated at 95 °C for 2 minutes. 
Samples were then treated with SHAPE reagent (10 mM final) or neat solvent.
SHAPE-MaP using fragmented samples
Following SHAPE modification and purification, HIV-1, group II intron, HCV IRES, and 
ribosomal RNA samples were fragmented (yielding lengths of ~250–350 nts) by a 4 min 
incubation at 94 °C in a buffer containing 9 mM MgCl2, 225 mM KCl, 150 mM Tris HCl 
(pH 8.3). RNA fragments were desalted using G-50 spin-columns. Fragmented samples 
(250–500 ng total mass) were subjected to reverse transcription for 3 hours at 42 °C (using 
SuperScript II, Invitrogen). Reactions were primed using 200 ng random nonamer primers 
(NEB) for the ribosome, group II intron, and HCV IRES RNA or with custom LNA primers 
(Supplementary Fig. 12) for HIV-1 RNA genomes. Reverse transcriptase buffer contained 
0.7 mM premixed dNTPs, 50 mM Tris HCl (pH 8.0), 75 mM KCl, 6 mM MnCl2, and 14 
mM DTT. Following reverse transcription, reactions were desalted using G-50 spin columns 
(GE Healthcare). Under these conditions (long incubation times and using 6 mM Mn2+ as 
the only divalent ion) the reverse transcriptase reads through sites of 2'-O-modification by a 
SHAPE reagent, incorporating a non-complementary nucleotide at the site of the adduct.
Double-stranded DNA libraries for massively parallel sequencing were generated using 
NEBNext sample preparation modules for Illumina. Second-strand synthesis (NEB E6111) 
of the cDNA library was performed using 100 ng input DNA, and the library was purified 
using a PureLink Micro PCR cleanup kit (Invitrogen K310250). End repair of the double-
stranded DNA libraries was performed using the NEBNext End Repair Module (NEB 
E6050). Reaction volumes were adjusted to 100 µL, subjected to a cleanup step (Agencourt 
AMPure XP beads A63880, 1.6:1 beads-to-sample ratio), dA tailed (NEB E6053), and 
ligated with Illumina-compatible forked adapters (TruSeq) with a quick ligation module 
(NEB M2200). Emulsion PCR44 (30 cycles) using Q5 hot-start, high-fidelity polymerase 
(NEB M0493) was performed to maintain library sample diversity. Resulting libraries were 
quantified (Qubit fluorimeter; Life Technologies), verified using a Bioanalyzer (Agilent), 
pooled, and subjected to sequencing using the Illumina MiSeq or HiSeq platform.
SHAPE-MaP using targeted gene-specific primers
The tRNAPhe, TPP riboswitch, 5S rRNA, group I intron, and mutant HIV-1 construct RNAs 
were subjected to reverse transcription using a DNA primer specific to either the 3' structure 
cassette (5'-GAA CCG GAC CGA AGC CCG-3') for the small RNAs or to specific HIV-1 
sequences flanking a pseudoknot using buffer and reaction conditions described in the 
previous section. Sequencing libraries were generated using a modular, targeted, two-step 
PCR approach that makes it possible to inexpensively and efficiently generate data for many 
different RNA targets. PCR reactions were performed using Q5 hot-start, high-fidelity DNA 
polymerase. The forward PCR primer (5'-GAC TGG AGT TCA GAC GTG TGC TCT TCC 
GATC NNNNN-gene-specific primer-3') includes an Illumina-specific region at the 5' end, 
followed by five random nucleotides to optimize cluster identification on the MiSeq 
instrument, and ends with a sequence complementary to the 5' end of the target RNA. The 
reverse primer (5'-CCC TAC ACG ACG CTC TTC CGA TCT NNNNN-gene-specific 
primer-3') includes an Illumina-specific region followed by five random nucleotides and a 
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sequence that is the reverse complement of the 3' end of the target RNA. The cDNA library 
was ‘tagged’ by limited, 5-cycle PCR for amplicons or a longer 25 cycle PCR reaction when 
very low RNA concentrations were used. Excess primer, not used in the first few cycles, 
was removed (PureLink Micro PCR cleanup kit; Invitrogen). The second round of PCR 
added the remaining Illumina-specific sequences needed for on-flow cell amplification and 
barcoded the samples for multiplexing. The forward primer (CAA GCA GAA GAC GGC 
ATA CGA GAT [Barcode] GT GAC TGG AGT TCA GAC) contains a barcode and targets 
sequence in the forward primer from PCR 1. The reverse primer (AAT GAT ACG GCG 
ACC ACC GAG ATC TAC ACT CTT T CCC TAC AC GAC GCT CTT CCG) contains an 
Illumina-specific sequence and targets the reverse primer from PCR 1. PCR 2 was 
performed for 25 or 5 cycles to generate the final library for sequencing (not exceeding 30 
total cycles). Typical SHAPE-MaP experiments of mutant viruses used ~150 to 200 ng of 
RNA per experimental condition. However, when material is limiting, as little as 50 ng input 
RNA is sufficient.
SHAPE-MaP data analysis pipeline
We created a data analysis pipeline, called ShapeMapper, that can be executed on most 
Unix-based platforms and accepts as input sequencing read files in FASTQ format, 
reference sequences in FASTA format, and a user-edited configuration file. Without further 
user intervention, the software creates a SHAPE reactivity profile and standard error 
estimates for each reference sequence. Other useful outputs are provided including mutation 
counts, sequencing depths, and predicted secondary structures. The analysis software 
incorporates several third-party programs. Python 2.7 is required (www.python.org); Bowtie 
2 is used for read alignment45; reactivity profiles are generated using the python library 
matplotlib46; secondary structure prediction uses RNAstructure47; and secondary structure 
drawing uses the Pseudoviewer web service48.
Configuration—A configuration file is used to specify the reference sequences present in 
each sample and which samples should be combined to create reactivity profiles. The format 
is flexible, allowing the alignment of each sample to multiple sequence targets as well as the 
treatment of multiple samples in unified analyses. Important parameters for each stage of 
analysis may also be customized.
Quality trimming—Input reads were separated into files by sequencing barcode (this step 
is integrated into most sequencing platforms). The first analysis stage trims reads by base-
call quality. Each read was trimmed downstream of the first base-call with a phred quality 
score below 10, corresponding to 90% expected accuracy. Reads with 25 or more remaining 
nucleotides were copied to new FASTQ files for alignment.
Read alignment—Reads were locally aligned to reference sequences using Bowtie 245; 
parameters were chosen to provide high sensitivity, to detect single nucleotide mismatches, 
and to allow deletions of up to about 200 nucleotides. Seed length (-L) was 15 nucleotides. 
One mismatch was allowed per seed (-N). Maximum seed attempts (-D) was set at 20. 
Maximum “re-seed” attempts (-R) was set at 3. Dynamic programming padding (--dpad) 
was set at 100 nucleotides. The match bonus (--ma) was 2. The maximum and minimum 
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mismatch penalties (--mp) were 6 and 2, respectively. Gap open and extend parameters (--
rdg, --rfg) were 5 and 1, respectively. The default minimum alignment score function was 
used. Soft-clipping was turned on. Paired-end alignment was used by default. Bowtie 2 
outputs aligned reads as SAM files.
Alignment parsing, ambiguous alignment removal, and mutation counting—
Paired-end reads in SAM files were combined, and higher-quality base-calls were selected 
where read pairs disagreed. Mismatches and deletions contribute to mutation counts; 
insertions were ignored. Since error-prone reverse transcription generates most of the 
mutations in each read, we treated a sequence change covering multiple adjacent nucleotides 
as a single mutation event located at the 3´-most nucleotide. If random primers were used, a 
region one nucleotide longer than the length of the primer was excluded from the 3´ end of 
each read. Reads with mapping qualities less than 30 were excluded. Deletions are an 
important part of the mutation signal, but deletions that are ambiguously aligned can blur 
this signal, preventing single-nucleotide resolution. To resolve this problem, a simple local 
realignment was performed to identify and remove ambiguously aligned deletions. The 
reference sequence surrounding a deletion was stored. The deletion was then slid upstream 
or downstream one nucleotide at a time to a maximum offset equal to the deletion length. At 
each offset, the surrounding reference sequence was compared to the stored sequence. If any 
offset sequence matched, this indicated a possible alternate alignment, and the deletion was 
excluded. This algorithm correctly identified ambiguous deletions in homopolymeric 
regions as well as repeated sequences.
Reactivity profile creation—The mutation rate (mutr) at a given nucleotide is simply the 
mutation count (mismatches and unambiguously aligned deletions) divided by the read 
count at that location. Raw reactivities were generated for each nucleotide using the 
following expression, where S corresponds to a SHAPE modified sample, U to untreated, 
and D to reaction under denaturing conditions:
(1)
The standard error (stderr) associated with the mutation rate at a given nucleotide in the S, 
U, or D samples was calculated as:
(2)
The final standard error of the reactivity at a given nucleotide is:
(3)
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Reactivities were normalized to a standard scale that spanned zero (no reactivity) to ~2 (high 
SHAPE reactivity) as described22. Nucleotides with mutation rates greater than 5% in no-
reagent control samples were excluded from analysis, as were nucleotides with sequencing 
depths less than 10 in any sample. A much greater depth is required for high-quality data 
and structure modeling (see Fig. 3).
Final data output—SHAPE reactivity profiles (.shape) were output as tab-delimited text 
files with the first column indicating nucleotide number and the second reactivity. A 
SHAPE-MaP reactivity file was also output (.map). This file is in the SHAPE file format 
with the addition of two columns: standard error and nucleotide sequence. Another file 
(.csv) containing mutation counts, read depths, mutation rates, raw reactivities, normalized 
reactivities, and standard errors for SHAPE modified, untreated, and denatured samples was 
also created. Files containing figures showing mutation rate histograms, sequencing depths, 
and reactivity profiles may be generated (.pdf). These are useful in diagnosing potential 
experimental problems (including insufficient sequencing depth or low mutagenesis 
efficiency).
Automatic RNA folding and structure drawing by the SHAPE-MaP pipeline—
For sequences shorter than ~4000 nucleotides and with sufficient read depth, the automated 
pipeline allows secondary structures to be automatically modeled using RNAstructure, 
although this capability was not used for the RNAs in this work. FASTA sequence files are 
converted to SEQ files required by RNAstructure. SHAPE reactivities are incorporated into 
RNAstructure as pseudo-free energies using standard parameters for the 1M7 reagent22 
[slope (-sm) 1.8, intercept (-si) −0.6]. Differential SHAPE reagents are supported by 
RNAstructure, but have not been incorporated into the automated pipeline at the time of 
submission. Predicted structures are written to .ct files. The lowest energy predicted 
secondary structures can be drawn and annotated by SHAPE reactivity. This stage queries 
the Pseudoviewer web service48 over an active internet connection. A custom client 
(pvclient.py) submits server requests and retrieves responses. This client also handles 
coloring of nucleotides by reactivity. Colored structure drawings are vector .eps files. 
Structures are also automatically converted to .xrna files (http://rna.ucsc.edu/rnacenter/xrna/) 
for optional manual editing.
Filtering by Z-factor for differential SHAPE data
SHAPE-MaP allows errors in SHAPE reactivity measurements to be estimated from a 
Poisson distribution describing the measured mutation rates at each nucleotide. The Poisson-
estimated SHAPE reactivity error can be used to evaluate statistical significance when 
comparing two SHAPE signals. Significant differences between NMIA and 1M6 reactivity 
were identified using a Z-factor test49. This nucleotide-resolution test compares the absolute 
difference of the means with the associated measurement error:
(4)
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Each nucleotide in a SHAPE-MaP experiment has a calculated reactivity µ and an associated 
standard error σ. The significance threshold for Z-factors was set at Z > 0, equivalent to a 
SHAPE reactivity difference for 1M6 and NMIA of at least three standard deviations. 
Differential nucleotide reactivities not meeting this significance criterion were set to zero.
Structure modeling
Secondary structure modeling for RNAs less than 700 nts in length was performed as 
described19,22; differential SHAPE data were incorporated after filtering by Z-factor. For the 
HIV-1 RNA genome, we developed an automated windowed modeling approach, 
implemented in a SHAPE-MaP Folding Pipeline, in which structure calculations were 
broken into stages designed to increase computational efficiency, generate realistic RNA 
structures, and reduce end-effects caused by selecting a false 5' or 3' end from an internal 
fold in a window. This approach facilitated pseudoknot discovery, identification of probable 
base pairs, and generation of minimum free energy structures (Supplementary Fig. 2). 
Representative calculations for folding of ribosomal subunits, performed using both one-step 
and windowed folding showed comparable, high degrees of accuracy and substantial 
reductions in computation ‘wall time’ using a typical desktop workstation for the windowed 
folding approach. For shorter RNAs, such as the 16S rRNA, there is a modest performance 
penalty for breaking the RNA into smaller windows. However, for RNAs longer than ~2000 
nucleotides, computation time scales approximately linearly with length.
Nearly all known and well-validated functional RNA structures are modeled identically in 
the current study and the prior 2009 investigation27 (Table S1). Substantial improvements in 
digital (MaP) data acquisition, improved SHAPE-based energy functions19,22 and automated 
data analysis (Supplementary Figs. 1–3) favor the the current second-generatation HIV-1 
structure models over previous models in regions of disagreement. This work also reflects 
other innovations and analysis, notably that not all regions of an RNA are likely to form a 
single well-defined structure. As a result, an important component of the current work is the 
identification of regions in the HIV-1 RNA genome that do not form single well-defined 
structures.
Pseudoknot prediction—During the first stage, the full-length HIV-1 RNA genome was 
folded in 600-nt sliding windows moved in 100-nt increments using ShapeKnots with slope, 
intercept, P1, and P2 parameters set to previously defined values (1.8, −0.6, 0.35, 0.65) 
using 1M7- SHAPE data19,22. Additional folds were computed at the ends of the genome to 
increase the number of windows that cover terminal sequences. Predicted pseudoknots were 
retained if the structure appeared in a majority of windows and had low SHAPE reactivity 
on both sides of the pseudoknotted helix. This list of pseudoknots was used for all later 
stages of modeling.
Partition function modeling—The partition function was calculated using Partition26,47 
and included both 1M7 and differential SHAPE data in the free energy penalty. The max 
pairing distance was set to 500 nts. Partition was run in 1600-nt windows with a step size of 
375 nts. Two extra windows (lengths of 1550 and 1500 nts) were run on the 5' and 3' end 
sequences to increase sampling at the true ends and to reduce the effect of non-optimal cut 
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site selection. Six sequences (the primer binding site, dimerization sequence, and four 
pseudoknots known to be involved in unusual or special interactions) were constrained as 
single stranded during partition function calculations. From the individual partition function 
files, the Shannon entropy of base pairing was calculated as:
(5)
Where pi,j is the probability of pairing for nucleotides i and j over all potential J partners25. 
Following this calculation, 300 nts were trimmed from the 5' and 3' ends of each window 
that did not flank the true 5' and 3' ends of the RNA. This calculation retained more 
consistent internal values and discarded values skewed by end effects. Shannon entropy 
windows were combined by averaging, creating a single entropy file.
Individual probable pairs from each window were then trimmed using the same approach 
outlined for the Shannon entropy. Base pairs that formed with a probability less than 10−4 
were removed to decrease computation time. Windows were combined, and all remaining 
pairs were averaged over all of the windows in which they could have appeared. A heuristic 
color scale was developed from the combined partition file to indicate relative likelihood of 
a pair appearing in the final structure. The resulting pairs were plotted as arcs (Fig. 4). Base 
pairs with a probability greater than 0.99 were used as double-stranded constraints in the 
next step.
Minimum free-energy modeling—A minimum free energy structure was generated 
using Fold47, 1M7 SHAPE data, and differential SHAPE data. A window size of 3,000 nts 
with a step size of 300 nts was used to generate potential structures over each window. Four 
folds (3100, 3050, 2950, and 2900 nts from the ends) were also generated to increase the 
number of structure models at the termini. These folds from overlapping windows were then 
combined into a complete structure by comparing base pairs common to each window and 
requiring that pairs in the final structure appear in a majority of potential windows. As a 
final step, pseudoknotted helices were incorporated (Supplementary Fig. 2).
Error analysis and determining a minimum number of reads required for accurate RNA 
structure modeling
The mutation rates for each of the contributing signals (SHAPE modified, untreated, 
denatured) were modeled using a Poisson distribution because discrete events from 
individual reads contribute to the overall signal. The variance of a Poisson distribution is 
equal to the number of observations; thus, the standard error of a ‘true’ rate can be modeled 
as:
(6)
where λ is the number of events (mutations observed), reads is the read depth at the modeled 
nucleotide (both mutations and non-mutations), and rate is the number of events per read. 
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As expected, bootstrapping of the standard error of SHAPE reactivity showed an x−1/2 
power relationship as a function the read depth (Supplementary Fig. 6).
Using a deeply sequenced RNA (greater than 50,000 reads for each nucleotide), the number 
of expected mutation events at much lower read depths is known with high precision. 
Mutation events can be sampled from a Poisson distribution across the entire RNA to create 
profiles of plausible SHAPE data. To determine a minimum threshold for number of reads 
necessary for accurate SHAPE-directed secondary structure modeling, we examined the 16S 
rRNA because it is modeled poorly in the absence of experimental data (~50% sensitivity). 
For each simulated read depth, we created 100 SHAPE trajectories based on the expected 
Poisson variance at the simulated read depth and modeled it using RNAstructure Fold (Fig. 
3b). As expected, modeling accuracy improved as read depth increased. For accurate 
nucleotide resolution structure modeling, we recommend at least 5000 reads; however, even 
at 500 reads, the measurement is useful for structure modeling (Fig. 3b).
Hit level calculation and comparison with other reports
SHAPE-MaP structure analysis as read out by massively parallel sequencing presents a 
valuable tool for structural interrogation of RNA at a single nucleotide level. Several other 
approaches have been developed with similar goals. To compare the read depth requirement 
of SHAPE-MaP (and its mutational profiling readout) with other approaches, we calculated 
a “hit level”. The hit level metric quantifies the total background-subtracted signal per 
nucleotide of transcript:
(7)
where the subscripts S and B indicate the experimental sample and background control, 
respectively; events are either ligation-detected sequence stops or mutations, depending on 
readout method, and read depth corresponds to the median number of reads overlapping 
each nucleotide in the transcript. We obtained a hit level of 160 for the 16S rRNA. Since 
mutation counts in SHAPE-MaP are proportional to read depths, we estimated the 
relationship between our sequencing read depth and hit level by dividing our observed hit 
level by the median read depth in an experimental condition. A hit level of ~15 is required to 
fully recover RNA structure information as interrogated by SHAPE, although highly useful 
structure models were consistently obtained at hit levels as low as 5 (Fig. 3b).
High-resolution RNA structure probing and modeling requires that most or all of an RNA be 
interrogated at a high hit level. Individual regions probed at low hit levels, even if the 
overall average hit level is ≥5, are likely to contain notable errors. In PARS experiments, a 
minimum threshold of 1 average read stop per nucleotide of transcript was required5,50, 
corresponding to hit level of 1, assuming zero background for enzymatic cleavage data. 
Similarly, a report describing DMS chemical probing, structure-seq, used a similar threshold 
of ≥1 average stop per A or C nucleotide10; this corresponds to an estimated hit level (by our 
definition) of 0.2, assuming a signal:background ratio of 1.7 (estimated from Extended Data 
Fig. 1, panel d in ref. 10) and that half of all transcript nucleotides are A or C. A minimum 
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of 15 reads per A or C on average was required by the creators of DMS-seq11. This 
corresponds to a hit level of 3.3, assuming a signal:background ratio of 1.8 (estimated from 
Fig. 1, panel c in ref. 11). The benchmarking and bootstrapping analysis for modeling 
accuracy reported here (Fig. 3b) has not been implemented in prior massively parallel 
sequencing-based RNA structure analyses5,7,8,10,11,50; the authors of SHAPE-seq8 and Mod-
seq51 have independently noted the importance of read depth in obtaining quantitative RNA 
structure probing information.
This hit level analysis emphasizes that, although several prior studies have been performed 
in which the full complement of RNAs in a given transcriptome were present during the 
probing phase of the experiment, only a few thousand nucleotides in each case were sampled 
at a depth consistent with recovery of the underlying structure information obtainable using 
DMS or enzyme probes.
Algorithmic discovery of HIV-1 regions with low Shannon entropy and low SHAPE 
reactivity
Overlaps of regions with both low SHAPE reactivity and low Shannon entropy were used to 
identify regions likely to have a single well-determined structure. First, local median 
SHAPE reactivity and Shannon entropy were calculated over centered sliding 55-nt 
windows. Next, we selected regions in which the local median fell below the global median 
for more than 40 nts in both Shannon entropy and SHAPE reactivity. Regions were 
combined if they were separated by fewer than 10 nts. Finally, regions were expanded to 
include nested secondary structures from the minimum predicted free-energy model.
To exclude the possibility that the algorithmically discovered structured regions overlapped 
known RNA elements merely by chance, we generated a randomized pool of segments and 
calculated the expected distribution of overlapping nucleotides (Table S2). We maintained 
the same number and length of segments but randomized their locations within the 9173-nt 
genome. Out of 105 trials, only 219 showed a larger overlap than we observed, 
corresponding to a p-value of 0.002.
HIV-1 mutagenesis
Mutations were introduced into HIV-1 pNL4-3 subclones spanning the region of interest by 
site-directed mutagenesis (QuikChange XL, Agilent) and verified by sequencing. The 
mutated subclone fragment was re-introduced into the full-length pNL4-3 plasmid52. The 
full-length mutant genome sequence was verified by conventional automated sequencing 
using 16 or more overlapping primers. Viruses from mutant and wild-type NL4-3 plasmids 
were produced by transfection as outlined above (to yield ~12 ng viral RNA per mL viral 
supernatant). Virion production was measured by p24 assay (AlphaLISA HIV p24 kit, 
PerkinElmer AL207C). Viruses were measured for infectivity on TZM-bl indicator cells53 
(using Glo Lysis buffer and the Luciferase Assay System; Promega).
Mutations were designed to disrupt the primary pseudoknot sequence but maintain amino 
acid identity in coding sequences (Supplementary Fig. 8). The primary pseudoknotted helix 
in U3PK partially overlaps a binding site for transcription factor SP1. A total of three 
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consecutive SP1 binding sites exist in HIV-1. Two point mutations introduced into the U3PK 
construct overlap the third SP1 binding site. Previous work has demonstrated that only a 
single binding site is required for complete viral function54. The SP1 protein tolerates 
variation at several places in the binding consensus sequence and the mutations introduced 
here maintained a canonical SP1 binding site. To analyze effects on virus production due to 
the SP1 mutation, the same U3 mutations were introduced into the 5' U3 region of the 
pNL4-3 clone (with and without concomitant 3' mutations). The resulting viruses had either 
no phenotype (the 5' U3 mutations alone) or the same phenotype as the original U3PK 
mutant (those containing both 5' and 3' U3 mutations), suggesting that alteration of the SP1 
binding site did not disrupt viral RNA production. The double mutant species was used for 
viral spread and competition assays as described below.
Separation of mutant U3PK and wild-type NL4-3 SHAPE-MaP data
Gene-specific primer SHAPE-MaP data for U3PK (for the construct in which the 3' U3 alone 
was mutated) revealed that the three nucleotides targeted for mutagenesis showed unusually 
high mutation rates when aligned to the mutant sequence, suggesting the presence of 
multiple sequence populations. Quantifying the relative abundance of each variant sequence 
showed that 61.8% of reads contained the native sequence, 36.0% contained the designed 
mutant sequence, and a small fraction (2.2%) contained other sequences (Fig. 5a, 
Supplementary Fig. 10). These ratios suggest that recombination between the native 
sequence and mutant U3 regions occurred during transfection producing fitter HIV-1 virus 
that grew more rapidly than the mutant virus during virus culture. This mutant virus was 
grown in H9 cells (ATCC) for 3 weeks prior to RNA extraction and SHAPE-MaP testing. 
Reactivity profiles for the designed mutant and the wild-type sequence were created by 
computationally separating the reads after alignment (Fig. 5b). In addition, SHAPE-MaP 
reactivity data for the three mutated nucleotides were obtained by selecting reads targeting 
two mutated nucleotides at a time to assign wild-type or mutant membership, allowing 
variation at the third nucleotide to determine the mutation rate. This approach is widely 
applicable to chemically probing populations of RNAs in which each sequence fraction is 
larger than the expected reverse transcription-induced per-nucleotide mutation rate (~1% in 
this work).
HIV replication assays
Viruses were tested for cell-to-cell spread in Jurkat (ATCC) and H9 T-cell lines. Virus 
inocula were normalized by TZM-bl infectivity at a low multiplicity of infection (less than 
0.01) prior to infection and used to infect 5 × 105 cells in 1 mL RPMI-1640 medium in 12-
well plates; infections were carried out in duplicate. A full medium change was performed 3 
days post-infection (dpi), and the medium in each well was harvested and replaced 4, 5, and 
6 dpi. Viral concentrations were quantified by p24 assay (AlphaLISA HIV; PerkinElmer).
HIV competition assays
Mutant and native sequence virus were mixed at a 10:1 ratio, respectively, and used to infect 
5 × 105 Jurkat cells in 1 mL total volume in 12-well plates. Infections were performed using 
half as much mutant and 20-fold less wild-type virus relative to the viral replication assays. 
Competition experiments were carried out in duplicate. Medium was initially harvested at 2 
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dpi to represent the initial inoculum. The medium was harvested at 3, 4, 5, and 6 dpi, and 
p24 (capsid protein) was quantified in medium (AlphaLISA HIV p24 kit). We required that 
p24 levels increase exponentially through day 6 to ensure that uninfected cells were in 
excess through the infections. Viral RNA was purified from medium (QIAamp viral RNA 
mini kit, Qiagen) and reverse transcription using SuperScript III (Life Technologies) was 
carried out using Primer ID primers55 to barcode each cDNA produced and eliminate 
population biases introduced during PCR. Subsequent sample preparation was performed as 
described above for SHAPE-MaP using targeted gene-specific primers.
After sequencing, paired-end reads were merged into longer synthetic reads using FLASh 
(Fast Length Adjustment of Short reads)56. Next, synthetic reads were aligned to the 
expected NL4-3 sequence for the targeted regions using Bowtie 245 (using default 
parameters). A consensus read was built for each PrimerID based on a Phred score voting 
metric. IDs matching either native or mutant sequences were required to have the expected 
point mutations in all locations in order to be considered. The fraction of mutant IDs was 
expressed as the number of mutant IDs out of the sum of mutant and native IDs. Relative 
fitness of mutant viruses was determined from the rate of change of the ratio of mutant to 
NL4-3 measured over time31.
Calculation of differences in SHAPE reactivities in pseudoknot mutants
Standard error measurements of SHAPE reactivities, estimated from the Poisson 
distribution, are dependent on the number of reads obtained for each sample. The 
observation that standard error decreases with the inverse square of read depth 
(Supplementary Fig. 6) was used to derive a scaling equation that normalizes to a common 
depth of 8000 reads to account for differences in sequencing depth between samples. The 
standard error scaling factor, f0, was calculated for each sample based on the average read 
depth, rave, of the lowest sequenced component (SHAPE modified, untreated, and 
denaturing conditions) contributing to the SHAPE reactivity profile:
(8)
After scaling standard errors to a common read depth, significance for each point was 
calculated using a modified z-factor test49 requiring differences to be greater than 1.96 times 
the sum of the standard errors. Z-factor scores greater than zero were considered significant:
(9)
Isolated reactivity changes can be viewed as noise in the context of a global structure shift 
resulting from disruption of a pseudoknot. Therefore, in addition to the z-factor test, 
differences were required to be consecutive.
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Figure 1. SHAPE-MaP Overview
RNA is treated with a SHAPE reagent that reacts at conformationally dynamic nucleotides. 
Reverse transcription is carried out under conditions such that the polymerase reads through 
chemical adducts in the RNA and incorporates a nucleotide non-complementary to the 
original sequence (in red) into the cDNA. The resulting cDNA is sequenced using any 
massively parallel approach to create mutational profiles (MaP). Sequencing reads are 
aligned to a reference sequence, and nucleotide-resolution mutation rates are calculated, 
corrected for background and normalized, producing a standard SHAPE reactivity profile. 
SHAPE reactivities can then be used to model secondary structures, visualize competing and 
alternative structures, or quantify any process or function that modulates local nucleotide 
RNA dynamics.
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Figure 2. Nucleotide-resolution interrogation of RNA structure and ligand-induced 
conformational changes
(a) Mutation rate profiles for the SHAPE modified and untreated TPP riboswitch RNA in 
the presence of ligand (top) and for SHAPE modification performed under denaturing 
conditions (bottom). (b) Quantitative SHAPE profile obtained after subtracting the data from 
the untreated sample from data for the treated sample and normalizing by the denatured 
control. (c) SHAPE reactivities plotted on the accepted secondary structure of the ligand-
bound TPP riboswitch. Red, orange, and black correspond to high, moderate, and low 
reactivities, respectively. (d) Difference SHAPE profile showing conformational changes in 
the TPP riboswitch upon ligand binding. (e) Superposition of ligand-induced conformational 
changes on the TPP riboswitch structure.
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Figure 3. Accuracy of SHAPE-MaP-directed secondary structure modeling
(a) Secondary structure modeling accuracies reported as a function of sensitivity (sens) and 
positive predictive value (ppv) for calculations performed without experimental constraints, 
with conventional capillary electrophoresis (CE) data, and with SHAPE-MaP data obtained 
with the 1M7 reagent22,38 or with three-reagent differential (Diff) data19. Results are colored 
on a scale to reflect low (red) to high (green) modeling accuracy. (b) Relationship between 
sequencing read depth, hit level, and accuracy of RNA structure modeling. Structure 
prediction accuracy (vertical axis) is shown as the geometric average of the sens and ppv of 
Siegfried et al. Page 24













predicted structures with respect to the accepted model38. For the 16S rRNA, this accuracy 
ranges from 50% in the absence of experimental data to 89% for single-reagent SHAPE 
(shown), and to 91% for the three-reagent “differential”19 experiment. Boxplots summarize 
modeling the secondary structure of the 16S ribosomal RNA as a function of simulated 
SHAPE-MaP read depth. At each depth, 100 folding trajectories were sampled. The line at 
the center of the box indicates the median value and boxes indicate the interquartile range. 
Whiskers contain data points that are within 1.5 times the interquartile range and outliers are 
indicated with (+) marks. Hit level is the total signal above normalized background per 
transcript nucleotide.
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Figure 4. SHAPE-MaP analysis of the HIV-1 NL4-3 genome
(a) SHAPE reactivities for the NL4-3 HIV-1 genomic RNA. Reactivities are shown as the 
centered 55-nt median window, relative to the global median; regions above or below the 
line are more flexible or constrained than the median, respectively. Shannon entropy values 
for 55-nt windows were calculated by considering the pairing probability of a nucleotide 
over all structures in a 1M7 and differential SHAPE19 reactivity data-constrained Boltzmann 
ensemble and reflect how well determined the secondary structure model is for each 
nucleotide region. Arcs representing base pairs are colored by their respective pairing 
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probabilities, with green arcs indicating highly probable helices. Areas with many 
overlapping arcs have multiple potential structures. Pseudoknots (PK) are indicated by black 
arcs. (b) RNA regions identified as having biological functions. Brackets enclose well-
determined regions and are drawn to emphasize locations of these regions relative to known 
RNA features in the context of the viral genome. Regions correspond to low SHAPE-low 
Shannon entropy domains and are extended to include all intersecting helices from the 
lowest predicted free-energy secondary structure. 5’ and 3’ UTRs are brown; splice 
acceptors and donors are green and blue, respectively; polypurine tracts are yellow; variable 
domains are purple; and the frameshift and RRE domains are red. These elements fall within 
regions with low SHAPE and low Shannon entropy much more frequently than expected by 
chance (p = 0.002; see Online Methods). (c) Secondary structure models for regions, 
identified de novo, with low SHAPE reactivities and low Shannon entropies. Nucleotides are 
colored by SHAPE reactivity and pseudoknotted structures are labeled in blue. Larger figure 
images, showing nucleotide identities, are provided in Supplementary Fig. 7.
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Figure 5. Functional and structural validation of newly discovered HIV-1 RNA motifs
(a) Scheme for simultaneous deconvolution and structural analysis of a mixture of native 
sequence and U3PK mutant genomes.(b) SHAPE profiles for the U3PK pseudoknot bridging 
U3 and R. The experiment simultaneously probed a mixture of viruses with native sequence 
and mutant U3PK RNAs. Secondary structure for the native sequence is shown as arcs below 
the y-axis intercept. Significant SHAPE reactivity differences are emphasized with yellow 
vertical lines (see Online Methods). (c) Direct growth competition and viral spread for U3PK 
mutant and native sequence NL4-3 HIV-1 virions in Jurkat cells. Percentage of mutant in the 
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initial inoculum is presented as a grey square at day 0. p24 levels correspond to the amount 
of HIV-1 capsid protein. (d) SHAPE profiles for the RTPK pseudoknot within the reverse 
transcriptase coding region. In this case, SHAPE data were obtained in separate experiments 
for each virus. (e) Viral spread and direct growth competition for RTPK mutant and native 
sequence NL4-3 HIV-1 virions in Jurkat cells. For the competition data, y-axes are shown 
on an expanded scale for clarity.
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